|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
LC|no2016169795
(VIAF cluster)
(Authority/Source Record)
|
|
005
|
|
|
20161222054029.0 |
|
008
|
|
|
161220n| azannaabn |n aaa c |
|
003
|
|
|
LC |
|
035
|
|
|
‡a
(LC)10340080
|
|
010
|
|
|
‡a
no2016169795
|
|
035
|
|
|
‡a
(OCoLC)oca10663146
|
|
035
|
|
|
‡a
(DLC)10338242
|
|
035
|
|
|
‡a
(DLC)no2016169795
|
|
040
|
|
|
‡a
ABAU
‡b
eng
‡e
rda
‡c
ABAU
|
|
100
|
1 |
|
‡a
Thompson, Brad E.
|
|
373
|
|
|
‡a
National Institutes of Health (U.S.)
‡a
National Cancer Institute (U.S.)
‡2
naf
|
|
377
|
|
|
‡a
eng
|
|
670
|
|
|
‡a
Regulation of gene expression in eukaryotic cells, 1974:
‡b
title page (editor, Brad Thompson) page 127 (E. Brad Thompson, Laboratory of Biochemistry Biosynthesis Section, National Cancer Institute, National Institutes of Health, Bethesda, Md.)
|
|
919
|
|
|
‡a
regulationofgeneexpressionineukaryoticcells
‡A
Regulation of gene expression in eukaryotic cells, 1974:
‡9
1
|
|
943
|
|
|
‡a
197x
‡A
1974
‡9
1
|
|
948
|
|
|
‡a
eng
‡9
1
|
|
996
|
|
|
‡2
WKP|Q102210100
|
|
996
|
|
|
‡2
PLWABN|9812689073105606
|
|
996
|
|
|
‡2
JPG|500284982
|
|
996
|
|
|
‡2
WKP|Q104752362
|
|
996
|
|
|
‡2
ISNI|0000000041586627
|
|
996
|
|
|
‡2
BNE|XX5160238
|
|
996
|
|
|
‡2
ISNI|0000000410163807
|
|
996
|
|
|
‡2
WKP|Q2923493
|
|
996
|
|
|
‡2
WKP|Q89731012
|
|
996
|
|
|
‡2
ISNI|0000000034549422
|
|
996
|
|
|
‡2
ISNI|0000000119528321
|
|
996
|
|
|
‡2
WKP|Q96475395
|
|
996
|
|
|
‡2
WKP|Q2923445
|
|
996
|
|
|
‡2
NUKAT|n 2023185515
|
|
996
|
|
|
‡2
NSK|000244767
|
|
996
|
|
|
‡2
DBC|87097992321282
|
|
996
|
|
|
‡2
ISNI|0000000065106675
|
|
996
|
|
|
‡2
WKP|Q111230617
|
|
996
|
|
|
‡2
WKP|Q124635691
|
|
996
|
|
|
‡2
NUKAT|nx2022399514
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
|
998
|
|
|
‡a
Thompson, Brad.
‡2
NUKAT|n 2023185515
‡3
viafid
|
|
998
|
|
|
‡a
Thompson, Brad
‡2
ISNI|0000000065106675
‡3
exact name
|
|
998
|
|
|
‡a
Thompson, Brad E
‡2
ISNI|0000000065106675
‡3
exact name
|
